Panbela Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OTC.Pink
SCHEDULE 13D/A: Nant Capital and Patrick Soon-Shiong Secure Dominant Stake in Panbela Therapeutics Through $12 Million Convertible Note Investment
Nant Capital, LLC and Patrick Soon-Shiong have acquired the right to convert notes into 86.98% of Panbela Therapeutics, Inc.'s common stock, following a $12 million private placement of senior convertible promissory notes.